Sewage research: decline of novel coronavirus in the Netherlands The first results of RIVM’s National Wastewater Surveillance show that the novel coronavirus in sewage is decreasing in the Netherlands.
Results from the GGD test lanes for employees in education and childcare As of 1 June, anyone in the Netherlands with (mild) symptoms can be tested for COVID-19 in the GGD test lanes. People can sign up for a test, or be tested due to source and contact tracing.
Results from the GGD test lanes As of 1 June, anyone in the Netherlands with (mild) symptoms can be tested for COVID-19 in the GGD test lanes.
Many people willing to isolate at home in case of positive COVID-19 test The sense of threatening danger from the novel coronavirus is declining. People are feeling less anxious and despondent than in the initial phase of the coronavirus pandemic.
Corona crisis has limited impact on infant participation in National Immunisation Programme Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
Initial results on how COVID-19 spreads within Dutch families The novel coronavirus is primarily spread amongst adults who are about the same age. Within families, the virus is mainly transmitted from adults to children.
Benefits and bottlenecks for early marketing authorisation of new medicines Patients are asking increasingly often for quicker access to new, innovative medicines. This requires a more effective use of flexible marketing authorisation procedures.
European Baseline Report SUSTAIN The SUSTAIN project has published the European baseline report titled ‘Integrated care for older people living at home – Current situation and ambition of sites participating in the SUSTAIN project
Particle contamination on Silimed breast implants poses minimal risk Particles were found on Silimed silicone-based breast implants that should not be there. These included man-made mineral fibres, such as glasswool and rockwool.
EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.